Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.052 | 0.7 |